Latest News - Waters Corporation
Top Corporates Hub
Waters Corporation
Waters (WAT): Revisiting Valuation After Steady Multi‑Year Share Price Gains
18.12.2025 02:16
Waters (WAT) has quietly delivered steady long term gains, with shares up around 23% over the past 3 months and more than 50% over five years, despite recent short term softness. See our latest analysis for Waters. At around $377 per share, Waters has given investors a solid 23.09% 90 day share price return. Its 5 year total shareholder return above 50% points to steady, enduring momentum rather than a short lived spike. If Waters has you thinking about quality compounders in healthcare, it...
Morgan Stanley Highlights Positive Outlook for Becton, Dickinson (BDX) and the MedTech Sector
11.12.2025 07:13
Becton, Dickinson and Company (NYSE:BDX) is included among the 15 Best Stocks to Buy for the Long Term. On December 2, Morgan Stanley analyst Patrick Wood lifted the firm’s price target on Becton, Dickinson and Company (NYSE:BDX) to $210 from $197 and maintained an Overweight rating on the shares. The analyst noted that the company’s […]
3 Reasons to Sell WAT and 1 Stock to Buy Instead
10.12.2025 04:03
Waters Corporation trades at $386.11 per share and has stayed right on track with the overall market, gaining 10.4% over the last six months. At the same time, the S&P 500 has returned 13.4%.
Jim Cramer on Waters Corporation: “I Think It Should Be Loved on Wall Street
04.12.2025 05:05
Waters Corporation (NYSE:WAT) is one of the stocks Jim Cramer recently discussed. Cramer discussed the company’s upcoming merger with Becton, Dickinson’s biosciences and diagnostics business. He remarked: “Finally, please don’t forget about one that was always my personal favorite, never owned it for the trust, Waters Corporation, one of the quieter companies in this space […]
A Look At The Intrinsic Value Of Waters Corporation (NYSE:WAT)
02.12.2025 10:12
Key Insights The projected fair value for Waters is US$361 based on 2 Stage Free Cash Flow to Equity With US$398 share...
Waters Corporation to Present at the Jefferies Global Healthcare Conference in London
11.11.2025 19:00
Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on Tuesday, November 18th, 2025, at 2:30 PM Greenwich Mean Time (9:30 AM Eastern Time).
Waters Boosts Lab Productivity and Sample Throughput with Launch of its Charged Aerosol Detector Designed for Empower Software
11.11.2025 13:00
Waters Corporation (NYSE:WAT) today announced the launch of its Charged Aerosol Detector (CAD) specifically designed for use with Waters Empower Software, the world's most trusted chromatography data system (CDS). Waters is the global market leader in chromatography software solutions for regulatory filings, as Empower Software is used to submit data for approximately 80% of novel drugs to regulatory authorities.2
Waters Corporation (WAT) Slipped Following the Acquisition Announcement
04.11.2025 12:15
Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund rose 5.39% (Institutional Shares) in the quarter, compared to a 5.05% gain for the Russell 3000 Health Care Index (benchmark) and an 8.18% gain for the Russell 3000 […]
Waters Corporation (WAT) Q3 2025 Earnings Call Transcript
04.11.2025 11:56
Waters Corporation (WAT) Q3 2025 Earnings Call November 4, 2025 8:00 AM ESTCompany ParticipantsCaspar Tudor - Head of Investor RelationsUdit Batra -...
Waters Corporation (NYSE:WAT) Beats Q3 Sales Expectations
04.11.2025 11:46
Scientific instruments company Waters Corporation (NYSE:WAT) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 8% year on year to $799.9 million. The company expects next quarter’s revenue to be around $926.8 million, close to analysts’ estimates. Its GAAP profit of $2.50 per share was 14.7% below analysts’ consensus estimates.
Waters: Q3 Earnings Snapshot
04.11.2025 11:12
The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $3.21 per share. The maker of products used in drug discovery and development posted revenue of $799.9 million in the period, also topping Street forecasts.
Waters Corporation (NYSE: WAT) Reports Third Quarter 2025 Financial Results
04.11.2025 11:00
Waters Corporation (NYSE: WAT), today announced its financial results for the third quarter of 2025.
Waters (WAT): Exploring Valuation Potential Following Recent Share Price Dip
08.10.2025 09:11
Waters (WAT) shares have caught some attention lately, especially after a dip of nearly 3% in the latest trading session. With investors evaluating what is next for this life sciences giant, recent stock moves may offer fresh entry points. See our latest analysis for Waters. Over the past year, Waters’ share price return has been notably soft, with momentum fading after a strong run in previous years. Despite a recent 6% bounce over the last week, its year-to-date share price return stands at...
3 Reasons to Sell WAT and 1 Stock to Buy Instead
08.10.2025 04:04
Waters Corporation has been treading water for the past six months, recording a small return of 3.5% while holding steady at $318.35. The stock also fell short of the S&P 500’s 34.7% gain during that period.
Waters Merger Risks Weakening Its Competitive Moat
29.09.2025 05:28
Waters' merger with Becton, Dickinson and Companyâs Bioscience and Diagnostic Solutions business is a strategic move. Read why WAT stock is a Hold.
Waters Corporation (WAT) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)
04.09.2025 11:59
Waters Corporation discusses strong quarterly growth, strategic BD acquisition, and
Waters Corp (WAT) Q2 2025 Earnings Call Highlights: Strong Sales Growth and Raised Guidance
05.08.2025 07:09
Waters Corp (WAT) reports robust Q2 performance with 9% sales growth and raises full-year guidance, despite challenges in certain segments.